Darktrace, a start-up specializing in cybersecurity, has just completed a funding round of 65 million dollars (58.6 million euros) led by the investment fund KKR (Kolberg Kravis Robert). To carry out this operation, the British company was also able to count on the participation of Summit Partners, TenEleven Ventures and SoftBank via the SB ISAT Fund. This transaction allows Darktrace to pass the $ 100 million mark raised since its inception.
Founded in 2013 by Nicole Eagan, the Cambridge and San Francisco-based start-up offers companies defense solutions against cyber threats. To provide software adapted to the risks incurred by companies, Darktrace was directly inspired by the defense reflexes of the human body.
Technology based on the immune system
To transpose this principle to the Web, the start-up probes the computer networks of companies in order to understand the specificities of each device and the behavior of users. From this analysis, the technology developed by Darktrace detects and reacts to threats identified in real time that can cause damage to corporate networks.
With already offices in Paris, London, Milan, New York, Washington, Toronto, Auckland, Sydney, Singapore, Bombay and Tokyo, the British start-up sees further. With this new investment Darktrace plans to accelerate the global expansion of its “immune system” technology for businesses. The company from across the Channel has already claimed more than 1,000 customer deployments since its launch.